Qube Research & Technologies LTD Novo Nordisk A S Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Qube Research & Technologies LTD holds 720,131 shares of NVO stock, worth $100 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
720,131
Previous 17,400
4038.68%
Holding current value
$100 Million
Previous $1.8 Million
5036.89%
% of portfolio
0.15%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding NVO
# of Institutions
1,859Shares Held
310MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$2.93 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.91 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.81 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.67 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.64 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $313B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...